Clinical trials
Pertussis clinical trials
Below are recruiting pertussis clinical trials, each written for real people, not researchers. We’re tracking 20 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07203755RecruitingPhase 1
Combination vaccine for whooping cough, Hib, and meningitis
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
Shangqiu, HenanAges 2 months–6 years - NCT06344065RecruitingPhase 3
New whooping cough combo vaccine for 3-month-old infants
This trial tests a new combination vaccine that protects infants against diphtheria, tetanus, and whooping cough. It is for healthy 3-month-old babies whose parents have not yet given them a similar shot.
Nanning, GuangxiAges 3 months–3 months - NCT06827470RecruitingPhase 1
Whooping cough infection study in healthy adults
This study tests what happens when healthy adults are exposed to a special type of whooping cough bacteria. Results may help develop better vaccines to protect people from this infection.
Halifax, Nova ScotiaAges 18–50 - NCT07596199RecruitingPhase 3
Vaccine safety and immune response study in pregnant women
This study tests a vaccine that protects against three diseases—diphtheria, tetanus, and whooping cough—given during pregnancy. Researchers want to see if the vaccine is safe for pregnant women and their babies, and whether it helps protect newborns.
ChibaAges 18–45 - NCT05847322Recruiting
Pertussis challenge study with delayed antibiotic treatment
This study tests how well a “delayed antibiotic” plan works after being intentionally exposed to pertussis (whooping cough). It aims to learn whether delaying antibiotics for a short time is safe and useful, and you may be treated with an antibiotic if you become symptomatic.
Southampton, HampshireAges 18–55 - NCT05897879Recruiting
Study how pertussis germs and immune response affect severity
This study looks at children with suspected pertussis (who need a PCR test) and compares how the bacteria and the immune response relate to how sick they become. It may help doctors understand why some children have worse symptoms and guide future care.
BordeauxAges Up to 15 years - NCT06184542RecruitingPhase 1
New DTaP vaccine safety trial for children
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
Dazhou, SichuanAges 2 months–6 years - NCT06286007Recruiting
How whooping cough and RSV affect asthma in adults
This study looks at how infections like whooping cough and RSV impact asthma symptoms and control in adults. It aims to understand if these infections make asthma worse, which could help improve future treatment and prevention.
Santiago de Compostela, A CoruñaAges 18–99 - NCT06803524RecruitingPhase 4
10-year follow-up after a single pertussis shot
This study checks on people who got a single dose of a whooping cough vaccine about 10 years ago in a previous study. Researchers want to see how well the vaccine is still working and if it is still safe.
Bangkok Noi, Bangkok MetropolisAges Any age - NCT06947499RecruitingPhase 2/Phase 3
Testing a 6-in-1 infant vaccine in healthy babies
This study tests a new vaccine that protects babies against 6 diseases (diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib) in just one shot. It’s for healthy infants starting at 6–8 weeks old as their first series of vaccinations.
Dasmariñas, CaviteAges 1 month–2 months - NCT06333275Recruiting
Boosting immunity after CAR-T therapy
This trial checks if giving vaccines after CAR-T cell therapy can help your immune system fight off preventable diseases. It is for adults with certain blood cancers who are about to get CAR-T treatment.
BernAges 18 years+ - NCT06997627RecruitingPhase 1/Phase 2
Safety and immune response study of GC3111B vaccine in healthy adults
This trial tests a new vaccine called GC3111B to see if it is safe and helps the body build protection against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy adults who have not had a similar vaccine in the last 2 years.
SeoulAges 19–64 - NCT06639074RecruitingPhase 2
Folate receptor dendritic cell vaccine for ovarian cancer
This trial tests a personalized vaccine made from your own immune cells, designed to target a protein called folate receptor alpha found on many ovarian cancer cells. It is for people who have finished initial chemotherapy and have no signs of cancer remaining, to try to prevent it from coming back.
Scottsdale, ArizonaAges 18 years+ - NCT04807712Recruiting
Testing a pertussis workup for children at home visits
This trial studies children who might have pertussis (“whooping cough”). It looks at children in outpatient/home-care settings when the child’s doctor suspects pertussis and orders a lab test, to help guide evaluation and care.
CréteilAges 1 day–18 years - NCT06135636RecruitingPhase 4
Helping partners get the Tdap vaccine during pregnancy
This trial tests different ways to help partners of pregnant people get the Tdap vaccine (a shot that protects against tetanus, diphtheria, and whooping cough). The goal is to find the best way to increase vaccination rates among partners, which can help protect the newborn from whooping cough.
Providence, Rhode IslandAges 19–50 - NCT06605755Recruiting
Testing a pentavalent vaccine in 2-month-old babies
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
Nanjing, JiangsuAges 1.6 years–1.8 years - NCT06815250Recruiting
Boosting maternal vaccine knowledge and uptake: The InTroDuce-Programme
This trial tests a programme to help pregnant women learn about and get flu and Tdap vaccines. It aims to increase vaccination rates and improve health for mothers and babies.
Bandar Baru Bangi, SelangorAges 18 years+ - NCT07097012RecruitingPhase 4
Whooping cough and RSV vaccines: together or separate in pregnancy
This study tests whether giving two vaccines—one for whooping cough (Tdap) and one for RSV—at the same time is safe and effective compared to giving them separately during pregnancy. It may help protect your baby from both diseases early in life.
Vancouver, British ColumbiaAges 18–49 - NCT07358910Recruiting
Tracking infectious diseases in communities
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
Phnom Penh, Phnom PenhAges 2–75 - NCT07005726Enrolling by invitationPhase 4
BCG revaccination with DTP3 to reduce infant deaths in Africa
This study tests whether giving another BCG vaccine (the one for tuberculosis) at the same time as the third DTP shot can help reduce serious infections and deaths in babies in Africa. If your baby is healthy and getting their routine DTP3, this could be an option to possibly boost their overall protection.
BissauAges 3 months–6 months
Hear when a new Pertussis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pertussis?
- Yes. Clin2 currently lists 20 recruiting pertussis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pertussis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pertussis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.